The use of GAPSS significantly improved the prediction of the risk of thrombosis or pregnancy loss in SLE and transformed the concept of aPL as diagnostic antibodies to aPL as a risk factor for clinical events. The gene discussed is FASLG; the disease is Venous thrombosis.